Render Target: SSR
Render Timestamp:
4/3/2025, 3:29:51 PM EDT
4/3/2025, 7:29:51 PM UTC
Commit: 070ddbed3d58ff00053de84939cefdd328876779
XML generation date: 2025-03-11 22:02:15.664
Product last modified at: 2025-03-25T12:15:16.117Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

SRSF5 (F7Z3Y) Rabbit mAb #57885

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R Mk
    SENSITIVITY Endogenous
    MW (kDa) 42
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    SRSF5 (F7Z3Y) Rabbit mAb recognizes endogenous levels of total SRSF5 protein.

    Species Reactivity:

    Human, Mouse, Rat, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala101 of human SRSF5 protein.

    Background

    Serine/arginine-rich splicing factor 5 (SRSF5), also known as SRP40, is a member of the SR family of essential splicing proteins that bind to purine-rich enhancers (1-3). SRSF5 has a highly selective splicing motif and, like other SR proteins, is regulated by phosphorylation (4,5). The splicing activity of SRSF5 has been shown to regulate alternative splicing of key proteins in many processes, including fibronectin during liver proliferation, glucocorticoid receptor in hormone receptor signaling, and many HIV proteins during viral infection (6-8). Increased SRSF5 expression has been observed in breast cancer and non-small cell lung cancer (9,10).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.